跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,029 条关于
“5T4 antigen”
全部
5,029
临床试验
2,344
药物
990
机构
20
资讯
1,675
去年
ALG.APV-527 Bispecific Antibody Shows Promise in Phase 1 Solid Tumor Trial
去年
Purple Biotech to Present Novel CAPTN-3 Tri-Specific Antibody Platform at EACR 2025
去年
Aptevo's ALG.APV-527 Shows Promise in Solid Tumors with Favorable Safety Profile in Phase 1 Trial
去年
Purple Biotech Raises $6 Million in Public Offering to Advance Novel Cancer Immunotherapy Pipeline
9个月前
Purple Biotech's CAPTN-3 Platform Shows Promise Against Treatment-Resistant Cancers with Dual Tri-Specific Antibodies
去年
Tubulis' ADC TUB-030 Enters Phase I/IIa Trial for Advanced Solid Tumors
去年
Aptevo Therapeutics Secures $2.1 Million in Financing to Advance Immune-Oncology Pipeline
11个月前
Salubris Biotherapeutics Reports Promising Phase 1 Results for 5T4-Targeted ADC JK06 in Advanced Solid Tumors
5年前
Advancements in PSMA-Targeted Radionuclide Therapy for Metastatic Prostate Cancer
5个月前
Salubris Biotherapeutics Reports Promising Phase 1/2 Data for 5T4-Targeted ADC JK06 in Multiple Solid Tumors
第 1 页,共 168 页
上一页
下一页